Finally, whereas the evidence strongly supports a role for CSRP3 in HCM, its involvement in DCM remains less clear, necessitating further research to clarify its mechanistic contribution and potential as a therapeutic target in CMPs. The gene discussed is CSRP3; the disease is familial dilated cardiomyopathy.